Reference intervals for circulating angiogenic cytokines
Authors:
- Sun-Young KongSKSun-Young Kong
- Hye Lin LeeHLHye Lin Lee
- Hyeon-Seok EomHEHyeon-Seok Eom
- Weon-Seo ParkWPWeon-Seo Park
- Tak YunTYTak Yun
- Hyun-Ju KimHKHyun-Ju Kim
- Byung-Ho NamBNByung-Ho Nam
- Moon-Woo SeongMSMoon-Woo Seong
- Do-Hoon LeeDLDo-Hoon Lee
- 1 January 2008
- journal article
- research article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 46 (4) , 545-550
Abstract
Background : The levels of angiogenic cytokines are important in the definition of baseline characteristics of cancers and to predict patient prognosis; however, the reference intervals for angiogenic cytokines have received only limited attention. Herein, we obtained reference intervals for angiogenic cytokines, including vascular endothelial growth factor (VEGF), hepatocyte growth factor, basic fibroblast growth factor, interleukin-6, vascular endothelial growth factor receptor 1 and vascular endothelial growth factor receptor 2. Methods : We measured these materials in serum, plasma and urine of 131 controls, according to the guidelines of the Clinical and Laboratory Standards Institute. We analyzed the association between angiogenic cytokine levels and other laboratory parameters and explored whether polymorphisms in angiogenic cytokine genes affect the levels of cytokines. Results/Conclusions : These data allowed us to construct reference intervals for angiogenic cytokines, and we also observed that concentrations of angiogenic cytokines generally do not vary with genotype or haplotype. An exception was serum VEGF concentration; this level was marginally affected by the –1154 VEGF polymorphism. Clin Chem Lab Med 2008;46:545–50.Keywords
This publication has 23 references indexed in Scilit:
- Biological Determinants of and Reference Values for Plasma Interleukin-8, Monocyte Chemoattractant Protein-1, Epidermal Growth Factor, and Vascular Endothelial Growth Factor: Results from the STANISLAS CohortClinical Chemistry, 2006
- Angiogenesis in non-small cell lung cancer: The prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and bloodLung Cancer, 2006
- Simultaneous analysis of cytokines and co‐stimulatory molecules concentrations by ELISA technique andof probabilities of measurable concentrations of interleukins IL‐2, IL‐4, IL‐5, IL‐6, CXCL8 (IL‐8), IL‐10, IL‐13 occurring in plasma of healthy blood donorsMediators of Inflammation, 2006
- Angiogenesis and Lung Cancer: Prognostic and Therapeutic ImplicationsJournal of Clinical Oncology, 2005
- Accounting for Decay of Linkage Disequilibrium in Haplotype Inference and Missing-Data ImputationThe American Journal of Human Genetics, 2005
- Association between Expression of Transcription Factor Sp1 and Increased Vascular Endothelial Growth Factor Expression, Advanced Stage, and Poor Survival in Patients with Resected Gastric CancerClinical Cancer Research, 2004
- Antiangiogenesis drug promising for metastatic colorectal cancerThe Lancet, 2003
- Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinomaCancer, 2003
- A New Statistical Method for Haplotype Reconstruction from Population DataThe American Journal of Human Genetics, 2001
- Angiogenesis in cancer and other diseasesNature, 2000